Meltzer Jonathan C 4

4 · LABCORP HOLDINGS INC. · Filed Feb 10, 2026

AI-generated summary of this filing

Updated Feb 10, 2026

Labcorp (LH) EVP Jonathan Meltzer Receives RSUs, Sells Shares

What Happened

Jonathan C. Meltzer, EVP, Operations at Labcorp Holdings Inc. (LH), had Restricted Stock Units (RSUs) convert to common stock on Feb 6–7, 2026 (267 and 263 shares respectively; total 530 shares). To satisfy tax withholding, 173 shares were surrendered (91 shares at $277.20 = $25,225; 82 shares at $274.01 = $22,469). Separately, 88 shares were sold in an open‑market transaction on Feb 9, 2026 at $275.53 for proceeds of $24,247. Total reported proceeds/dispositions from these actions were about $71,941. The RSU conversions show $0 exercise price (conversion of award into shares).

Key Details

Transaction dates and prices:
- Feb 6, 2026: 267 RSUs converted to shares (disposition entry at $0.00).
- Feb 7, 2026: 263 RSUs converted to shares (disposition entry at $0.00).
- Feb 6, 2026: 91 shares withheld for taxes at $277.20 (value $25,225).
- Feb 9, 2026: 88 shares sold open market at $275.53 (proceeds $24,247).
- Feb 9, 2026: 82 shares withheld for taxes at $274.01 (value $22,469).
Shares after transactions: From this vesting event Meltzer received 530 shares, 261 were disposed (173 withheld + 88 sold), leaving roughly 269 newly issued shares retained from the vesting. The filing does not list his full total holdings of company stock.
Footnotes/other notes:
- F1: Each RSU converts to one share.
- F2: Stock withholding was used to satisfy tax obligations.
- F3: The open‑market sale was executed under a prearranged Rule 10b5‑1 plan.
- F4/F6: The RSUs were part of a grant that vests in two equal annual installments beginning Feb 6, 2026; vesting occurred Feb 6–7, 2026.
Filing timeliness: Reported on Feb 10, 2026 for transactions on Feb 6–9 — filed within the standard two business‑day Form 4 window.

Context

These were RSU vesting/conversion events (derivative conversion), not open purchases of stock. The use of share withholding to cover taxes and a 10b5‑1 plan sale are common, routine post‑vesting actions and do not by themselves indicate a change in insider sentiment.

Form 4

Period: 2026-02-06

EVP, Operations

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-06+267→ 2,785.326 total
Tax Payment
Common Stock
[F2]
2026-02-06$277.20/sh−91$25,225→ 2,694.326 total
Exercise/Conversion
Common Stock
[F1]
2026-02-07+263→ 2,957.326 total
Sale
Common Stock
[F3]
2026-02-09$275.53/sh−88$24,247→ 2,869.326 total
Tax Payment
Common Stock
[F2]
2026-02-09$274.01/sh−82$22,469→ 2,787.326 total
Exercise/Conversion
Restricted Stock Unit
[F1][F4][F5]
2026-02-06−267→ 2,580 total
→ Common Stock (267 underlying)
Exercise/Conversion
Restricted Stock Unit
[F1][F6][F5]
2026-02-07−263→ 2,317 total
→ Common Stock (263 underlying)

Footnotes (6)

[F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[F2]Stock withholding to satisfy tax withholding obligations.
[F3]Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
[F4]The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 6, 2026.
[F5]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
[F6]The Restricted Stock Units vested on February 7, 2026.

Signature

/s/ Kathryn W. Kyle, Attorney-in-Fact for Jonathan C. Meltzer|2026-02-10

1 file